{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T19:19:05Z","timestamp":1778613545325,"version":"3.51.4"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["IK2 BX003798-01A1"],"award-info":[{"award-number":["IK2 BX003798-01A1"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I01 BX002211-01A2"],"award-info":[{"award-number":["I01 BX002211-01A2"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["T32 AG-021890"],"award-info":[{"award-number":["T32 AG-021890"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG057964-01"],"award-info":[{"award-number":["R01AG057964-01"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["1RF1AG068283"],"award-info":[{"award-number":["1RF1AG068283"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["P30AG050911"],"award-info":[{"award-number":["P30AG050911"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["P30AG013319"],"award-info":[{"award-number":["P30AG013319"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["AARF-17-504221"],"award-info":[{"award-number":["AARF-17-504221"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000863","name":"Ellison Medical Foundation","doi-asserted-by":"publisher","award":["AG-NS-0726-10"],"award-info":[{"award-number":["AG-NS-0726-10"]}],"id":[{"id":"10.13039\/100000863","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013030","name":"William and Ella Owens Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020065","name":"San Antonio Medical Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1 TR002645"],"award-info":[{"award-number":["UL1 TR002645"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["GeroScience"],"DOI":"10.1007\/s11357-026-02294-9","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T17:26:45Z","timestamp":1778606805000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Regulation of survival, growth, and metabolism by neuronal mTOR"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1957-9086","authenticated-orcid":false,"given":"Stacy A.","family":"Hussong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel Burbank","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan J.","family":"Halloran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen F.","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Candice E.","family":"Van Skike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela O.","family":"Dorigatti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"DeRosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael E.","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa Y.","family":"Soto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel A.","family":"Pulliam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holly","family":"Van Remmen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven N.","family":"Austad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4501-8568","authenticated-orcid":false,"given":"Veronica","family":"Galvan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,5,12]]},"reference":[{"issue":"6","key":"2294_CR1","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.devcel.2022.02.024","volume":"57","author":"J Simcox","year":"2022","unstructured":"Simcox J, Lamming DW. The central moTOR of metabolism. Dev Cell. 2022;57(6):691\u2013706.","journal-title":"Dev Cell"},{"issue":"6","key":"2294_CR2","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","volume":"168","author":"RA Saxton","year":"2017","unstructured":"Saxton RA, Sabatini DM. mTOR signaling in growth, metabolism, and disease. Cell. 2017;168(6):960\u201376.","journal-title":"Cell"},{"issue":"6","key":"2294_CR3","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.cmet.2016.05.009","volume":"23","author":"BK Kennedy","year":"2016","unstructured":"Kennedy BK, Lamming DW. The mechanistic target of Rapamycin: the grand conductor of metabolism and aging. Cell Metab. 2016;23(6):990\u20131003.","journal-title":"Cell Metab"},{"issue":"15","key":"2294_CR4","doi-asserted-by":"publisher","first-page":"6710","DOI":"10.1128\/MCB.24.15.6710-6718.2004","volume":"24","author":"M Murakami","year":"2004","unstructured":"Murakami M, et al. mTOR is essential for growth and proliferation in early mouse embryos and embryonic stem cells. Mol Cell Biol. 2004;24(15):6710\u20138.","journal-title":"Mol Cell Biol"},{"issue":"6076","key":"2294_CR5","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1126\/science.1215135","volume":"335","author":"DW Lamming","year":"2012","unstructured":"Lamming DW, et al. Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity. Science. 2012;335(6076):1638\u201343.","journal-title":"Science"},{"issue":"5","key":"2294_CR6","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.cmet.2008.10.002","volume":"8","author":"CF Bentzinger","year":"2008","unstructured":"Bentzinger CF, et al. Skeletal muscle-specific ablation of raptor, but not of rictor, causes metabolic changes and results in muscle dystrophy. Cell Metab. 2008;8(5):411\u201324.","journal-title":"Cell Metab"},{"issue":"6","key":"2294_CR7","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1083\/jcb.200903131","volume":"187","author":"V Risson","year":"2009","unstructured":"Risson V, et al. Muscle inactivation of mTOR causes metabolic and dystrophin defects leading to severe myopathy. J Cell Biol. 2009;187(6):859\u201374.","journal-title":"J Cell Biol"},{"key":"2294_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s13395-016-0084-8","volume":"6","author":"M Guridi","year":"2016","unstructured":"Guridi M, et al. Alterations to mTORC1 signaling in the skeletal muscle differentially affect whole-body metabolism. Skelet Muscle. 2016;6:13.","journal-title":"Skelet Muscle"},{"issue":"5","key":"2294_CR9","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13014","volume":"18","author":"K Chellappa","year":"2019","unstructured":"Chellappa K, et al. Hypothalamic mTORC2 is essential for metabolic health and longevity. Aging Cell. 2019;18(5):e13014.","journal-title":"Aging Cell"},{"key":"2294_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2022.101580","volume":"65","author":"IC Frei","year":"2022","unstructured":"Frei IC, et al. Adipose mTORC2 is essential for sensory innervation in white adipose tissue and whole-body energy homeostasis. Mol Metab. 2022;65:101580.","journal-title":"Mol Metab"},{"issue":"6","key":"2294_CR11","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.molmet.2016.04.001","volume":"5","author":"PL Lee","year":"2016","unstructured":"Lee PL, et al. Raptor\/mTORC1 loss in adipocytes causes progressive lipodystrophy and fatty liver disease. Mol Metab. 2016;5(6):422\u201332.","journal-title":"Mol Metab"},{"issue":"1","key":"2294_CR12","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.celrep.2019.08.084","volume":"29","author":"D Yu","year":"2019","unstructured":"Yu D, et al. Calorie-restriction-induced insulin sensitivity is mediated by adipose mTORC2 and not required for lifespan extension. Cell Rep. 2019;29(1):236-248 e3.","journal-title":"Cell Rep"},{"issue":"18","key":"2294_CR13","doi-asserted-by":"publisher","first-page":"7799","DOI":"10.1523\/JNEUROSCI.3294-12.2013","volume":"33","author":"D Cloetta","year":"2013","unstructured":"Cloetta D, et al. Inactivation of mTORC1 in the developing brain causes microcephaly and affects gliogenesis. J Neurosci. 2013;33(18):7799\u2013810.","journal-title":"J Neurosci"},{"issue":"21","key":"2294_CR14","doi-asserted-by":"publisher","first-page":"4076","DOI":"10.1242\/dev.108282","volume":"141","author":"M Ka","year":"2014","unstructured":"Ka M, et al. mTOR regulates brain morphogenesis by mediating GSK3 signaling. Development. 2014;141(21):4076\u201386.","journal-title":"Development"},{"issue":"23","key":"2294_CR15","doi-asserted-by":"publisher","first-page":"8843","DOI":"10.1523\/JNEUROSCI.0887-15.2015","volume":"35","author":"OI Dadalko","year":"2015","unstructured":"Dadalko OI, et al. mTORC2\/Rictor signaling disrupts dopamine-dependent behaviors via defects in striatal dopamine neurotransmission. J Neurosci. 2015;35(23):8843\u201354.","journal-title":"J Neurosci"},{"issue":"6","key":"2294_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1000393","volume":"8","author":"MA Siuta","year":"2010","unstructured":"Siuta MA, et al. Dysregulation of the norepinephrine transporter sustains cortical hypodopaminergia and schizophrenia-like behaviors in neuronal rictor null mice. PLoS Biol. 2010;8(6):e1000393.","journal-title":"PLoS Biol"},{"issue":"5751","key":"2294_CR17","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1126\/science.1115535","volume":"310","author":"M Kaeberlein","year":"2005","unstructured":"Kaeberlein M, et al. Regulation of yeast replicative life span by TOR and Sch9 in response to nutrients. Science. 2005;310(5751):1193\u20136.","journal-title":"Science"},{"issue":"10","key":"2294_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.0050261","volume":"5","author":"O Medvedik","year":"2007","unstructured":"Medvedik O, et al. MSN2 and MSN4 link calorie restriction and TOR to sirtuin-mediated lifespan extension in Saccharomyces cerevisiae. PLoS Biol. 2007;5(10):e261.","journal-title":"PLoS Biol"},{"key":"2294_CR19","doi-asserted-by":"crossref","unstructured":"Powers RW 3rd, et al. Extension of chronological life span in yeast by decreased TOR pathway signaling. Genes Dev. 2006;20(2):174\u201384.","DOI":"10.1101\/gad.1381406"},{"issue":"1","key":"2294_CR20","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1474-9726.2006.00267.x","volume":"6","author":"M Hansen","year":"2007","unstructured":"Hansen M, et al. Lifespan extension by conditions that inhibit translation in Caenorhabditis elegans. Aging Cell. 2007;6(1):95\u2013110.","journal-title":"Aging Cell"},{"issue":"5","key":"2294_CR21","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.cmet.2012.04.007","volume":"15","author":"S Robida-Stubbs","year":"2012","unstructured":"Robida-Stubbs S, et al. TOR signaling and rapamycin influence longevity by regulating SKN-1\/Nrf and DAF-16\/FoxO. Cell Metab. 2012;15(5):713\u201324.","journal-title":"Cell Metab"},{"issue":"1","key":"2294_CR22","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.celrep.2014.08.075","volume":"9","author":"M Schieber","year":"2014","unstructured":"Schieber M, Chandel NS. TOR signaling couples oxygen sensing to lifespan in C. elegans. Cell Rep. 2014;9(1):9\u201315.","journal-title":"Cell Rep"},{"issue":"1","key":"2294_CR23","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cmet.2009.11.010","volume":"11","author":"I Bjedov","year":"2010","unstructured":"Bjedov I, et al. Mechanisms of life span extension by rapamycin in the fruit fly Drosophila melanogaster. Cell Metab. 2010;11(1):35\u201346.","journal-title":"Cell Metab"},{"issue":"10","key":"2294_CR24","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.cub.2004.03.059","volume":"14","author":"P Kapahi","year":"2004","unstructured":"Kapahi P, et al. Regulation of lifespan in Drosophila by modulation of genes in the TOR signaling pathway. Curr Biol. 2004;14(10):885\u201390.","journal-title":"Curr Biol"},{"issue":"5","key":"2294_CR25","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.celrep.2013.07.030","volume":"4","author":"JJ Wu","year":"2013","unstructured":"Wu JJ, et al. Increased mammalian lifespan and a segmental and tissue-specific slowing of aging after genetic reduction of mTOR expression. Cell Rep. 2013;4(5):913\u201320.","journal-title":"Cell Rep"},{"issue":"7253","key":"2294_CR26","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/nature08221","volume":"460","author":"DE Harrison","year":"2009","unstructured":"Harrison DE, et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature. 2009;460(7253):392\u20135.","journal-title":"Nature"},{"issue":"3","key":"2294_CR27","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1111\/acel.12194","volume":"13","author":"RA Miller","year":"2014","unstructured":"Miller RA, et al. Rapamycin-mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restriction. Aging Cell. 2014;13(3):468\u201377.","journal-title":"Aging Cell"},{"issue":"4","key":"2294_CR28","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1111\/j.1474-9726.2012.00832.x","volume":"11","author":"JE Wilkinson","year":"2012","unstructured":"Wilkinson JE, et al. Rapamycin slows aging in mice. Aging Cell. 2012;11(4):675\u201382.","journal-title":"Aging Cell"},{"issue":"2","key":"2294_CR29","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1093\/gerona\/glq178","volume":"66","author":"RA Miller","year":"2011","unstructured":"Miller RA, et al. Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice. J Gerontol A Biol Sci Med Sci. 2011;66(2):191\u2013201.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"24","key":"2294_CR30","doi-asserted-by":"publisher","first-page":"4230","DOI":"10.4161\/cc.10.24.18486","volume":"10","author":"VN Anisimov","year":"2011","unstructured":"Anisimov VN, et al. Rapamycin increases lifespan and inhibits spontaneous tumorigenesis in inbred female mice. Cell Cycle. 2011;10(24):4230\u20136.","journal-title":"Cell Cycle"},{"key":"2294_CR31","doi-asserted-by":"crossref","unstructured":"Bitto A et al Transient rapamycin treatment can increase lifespan and healthspan in middle-aged mice. Elife, 2016;5.","DOI":"10.7554\/eLife.16351"},{"issue":"8","key":"2294_CR32","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1172\/JCI67674","volume":"123","author":"F Neff","year":"2013","unstructured":"Neff F, et al. Rapamycin extends murine lifespan but has limited effects on aging. J Clin Invest. 2013;123(8):3272\u201391.","journal-title":"J Clin Invest"},{"issue":"11","key":"2294_CR33","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13269","volume":"19","author":"R Strong","year":"2020","unstructured":"Strong R, et al. Rapamycin-mediated mouse lifespan extension: late-life dosage regimes with sex-specific effects. Aging Cell. 2020;19(11):e13269.","journal-title":"Aging Cell"},{"issue":"1","key":"2294_CR34","doi-asserted-by":"publisher","first-page":"e83988","DOI":"10.1371\/journal.pone.0083988","volume":"9","author":"WC Fok","year":"2014","unstructured":"Fok WC, et al. Mice fed rapamycin have an increase in lifespan associated with major changes in the liver transcriptome. PLoS One. 2014;9(1):e83988.","journal-title":"PLoS One"},{"issue":"2","key":"2294_CR35","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/gerona\/glt056","volume":"69","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, et al. Rapamycin extends life and health in C57BL\/6 mice. J Gerontol A Biol Sci Med Sci. 2014;69(2):119\u201330.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"5","key":"2294_CR36","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1111\/acel.12109","volume":"12","author":"JM Flynn","year":"2013","unstructured":"Flynn JM, et al. Late-life rapamycin treatment reverses age-related heart dysfunction. Aging Cell. 2013;12(5):851\u201362.","journal-title":"Aging Cell"},{"issue":"2","key":"2294_CR37","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13086","volume":"19","author":"E Quarles","year":"2020","unstructured":"Quarles E, et al. Rapamycin persistently improves cardiac function in aged, male and female mice, even following cessation of treatment. Aging Cell. 2020;19(2):e13086.","journal-title":"Aging Cell"},{"issue":"6","key":"2294_CR38","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s11357-019-00119-6","volume":"41","author":"DF Dai","year":"2019","unstructured":"Dai DF, et al. Differential effects of various genetic mouse models of the mechanistic target of rapamycin complex I inhibition on heart failure. Geroscience. 2019;41(6):847\u201360.","journal-title":"Geroscience"},{"issue":"3","key":"2294_CR39","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1111\/acel.12203","volume":"13","author":"DF Dai","year":"2014","unstructured":"Dai DF, et al. Altered proteome turnover and remodeling by short-term caloric restriction or rapamycin rejuvenate the aging heart. Aging Cell. 2014;13(3):529\u201339.","journal-title":"Aging Cell"},{"key":"2294_CR40","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.neuroscience.2012.06.054","volume":"223","author":"J Halloran","year":"2012","unstructured":"Halloran J, et al. Chronic inhibition of mammalian target of rapamycin by rapamycin modulates cognitive and non-cognitive components of behavior throughout lifespan in mice. Neuroscience. 2012;223:102\u201313.","journal-title":"Neuroscience"},{"issue":"1","key":"2294_CR41","doi-asserted-by":"publisher","first-page":"e13057","DOI":"10.1111\/acel.13057","volume":"19","author":"CE Van Skike","year":"2020","unstructured":"Van Skike CE, et al. mTOR drives cerebrovascular, synaptic, and cognitive dysfunction in normative aging. Aging Cell. 2020;19(1):e13057.","journal-title":"Aging Cell"},{"issue":"41","key":"2294_CR42","doi-asserted-by":"publisher","first-page":"14042","DOI":"10.1523\/JNEUROSCI.2781-15.2015","volume":"35","author":"A Caccamo","year":"2015","unstructured":"Caccamo A, et al. Reducing ribosomal protein S6 kinase 1 expression improves spatial memory and synaptic plasticity in a mouse model of Alzheimer\u2019s Disease. J Neurosci. 2015;35(41):14042\u201356.","journal-title":"J Neurosci"},{"issue":"9","key":"2294_CR43","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1038\/jcbfm.2013.82","volume":"33","author":"AL Lin","year":"2013","unstructured":"Lin AL, et al. Chronic rapamycin restores brain vascular integrity and function through NO synthase activation and improves memory in symptomatic mice modeling Alzheimer\u2019s disease. J Cereb Blood Flow Metab. 2013;33(9):1412\u201321.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"4","key":"2294_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009979","volume":"5","author":"P Spilman","year":"2010","unstructured":"Spilman P, et al. Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer\u2019s disease. PLoS ONE. 2010;5(4):e9979.","journal-title":"PLoS ONE"},{"issue":"2","key":"2294_CR45","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/j.1474-9726.2011.00791.x","volume":"11","author":"S Majumder","year":"2012","unstructured":"Majumder S, et al. Lifelong rapamycin administration ameliorates age-dependent cognitive deficits by reducing IL-1beta and enhancing NMDA signaling. Aging Cell. 2012;11(2):326\u201335.","journal-title":"Aging Cell"},{"issue":"17","key":"2294_CR46","doi-asserted-by":"publisher","first-page":"13107","DOI":"10.1074\/jbc.M110.100420","volume":"285","author":"A Caccamo","year":"2010","unstructured":"Caccamo A, et al. Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-beta, and Tau: effects on cognitive impairments. J Biol Chem. 2010;285(17):13107\u201320.","journal-title":"J Biol Chem"},{"issue":"4","key":"2294_CR47","doi-asserted-by":"publisher","first-page":"H693","DOI":"10.1152\/ajpheart.00570.2017","volume":"314","author":"CE Van Skike","year":"2018","unstructured":"Van Skike CE, et al. Inhibition of mTOR protects the blood-brain barrier in models of Alzheimer\u2019s Disease and vascular cognitive impairment. Am J Physiol Heart Circ Physiol. 2018;314(4):H693-703.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"19","key":"2294_CR48","doi-asserted-by":"publisher","first-page":"4305","DOI":"10.1523\/JNEUROSCI.2144-20.2021","volume":"41","author":"CE Van Skike","year":"2021","unstructured":"Van Skike CE, et al. mTOR attenuation with rapamycin reverses neurovascular uncoupling and memory deficits in mice modeling Alzheimer\u2019s Disease. J Neurosci. 2021;41(19):4305\u201320.","journal-title":"J Neurosci"},{"issue":"1","key":"2294_CR49","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1177\/0271678X15621575","volume":"37","author":"AL Lin","year":"2017","unstructured":"Lin AL, et al. Rapamycin rescues vascular, metabolic and learning deficits in Apolipoprotein E4 transgenic mice with pre-symptomatic Alzheimer\u2019s disease. J Cereb Blood Flow Metab. 2017;37(1):217\u201326.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"37","key":"2294_CR50","doi-asserted-by":"publisher","first-page":"12833","DOI":"10.1523\/JNEUROSCI.0109-15.2015","volume":"35","author":"A Siddiqui","year":"2015","unstructured":"Siddiqui A, et al. Mitochondrial quality control via the PGC1alpha-TFEB signaling pathway is compromised by Parkin Q311X mutation but independently restored by rapamycin. J Neurosci. 2015;35(37):12833\u201344.","journal-title":"J Neurosci"},{"key":"2294_CR51","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1750-1326-8-31","volume":"8","author":"KA Staats","year":"2013","unstructured":"Staats KA, et al. Rapamycin increases survival in ALS mice lacking mature lymphocytes. Mol Neurodegener. 2013;8:31.","journal-title":"Mol Neurodegener"},{"key":"2294_CR52","doi-asserted-by":"publisher","DOI":"10.1177\/0271678X17705973","author":"JB Jahrling","year":"2017","unstructured":"Jahrling JB, et al. mTOR drives cerebral blood flow and memory deficits in LDLR-\/- mice modeling atherosclerosis and vascular cognitive impairment. J Cereb Blood Flow Metab. 2017. https:\/\/doi.org\/10.1177\/0271678X17705973.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"5","key":"2294_CR53","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.cmet.2012.03.015","volume":"15","author":"A Hagiwara","year":"2012","unstructured":"Hagiwara A, et al. Hepatic mTORC2 activates glycolysis and lipogenesis through Akt, glucokinase, and SREBP1c. Cell Metab. 2012;15(5):725\u201338.","journal-title":"Cell Metab"},{"key":"2294_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2025.118707","volume":"192","author":"X Xie","year":"2025","unstructured":"Xie X, et al. Inhibition of AKT or mTOR molecules mitigates obesity-associated metabolic disorders in Riz1(-\/-) mice with obesity. Biomed Pharmacother. 2025;192:118707.","journal-title":"Biomed Pharmacother"},{"issue":"11","key":"2294_CR55","doi-asserted-by":"publisher","first-page":"3120","DOI":"10.18632\/aging.101117","volume":"8","author":"PC Reifsnyder","year":"2016","unstructured":"Reifsnyder PC, et al. Rapamycin treatment benefits glucose metabolism in mouse models of type 2 diabetes. Aging (Albany NY). 2016;8(11):3120\u201330.","journal-title":"Aging (Albany NY)"},{"issue":"3","key":"2294_CR56","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.cmet.2013.02.008","volume":"17","author":"Y Fang","year":"2013","unstructured":"Fang Y, et al. Duration of rapamycin treatment has differential effects on metabolism in mice. Cell Metab. 2013;17(3):456\u201362.","journal-title":"Cell Metab"},{"issue":"5","key":"2294_CR57","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1111\/acel.12256","volume":"13","author":"DW Lamming","year":"2014","unstructured":"Lamming DW, et al. Depletion of Rictor, an essential protein component of mTORC2, decreases male lifespan. Aging Cell. 2014;13(5):911\u20137.","journal-title":"Aging Cell"},{"issue":"9","key":"2294_CR58","doi-asserted-by":"publisher","first-page":"742","DOI":"10.18632\/aging.100688","volume":"6","author":"Y Liu","year":"2014","unstructured":"Liu Y, et al. Rapamycin-induced metabolic defects are reversible in both lean and obese mice. Aging (Albany NY). 2014;6(9):742\u201354.","journal-title":"Aging (Albany NY)"},{"issue":"2","key":"2294_CR59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0211585","volume":"14","author":"KJ Kaiyala","year":"2019","unstructured":"Kaiyala KJ, Wisse BE, Lighton JRB. Validation of an equation for energy expenditure that does not require the respiratory quotient. PLoS One. 2019;14(2):e0211585.","journal-title":"PLoS One"},{"key":"2294_CR60","unstructured":"Team S ANCOVA Calculator. StatsCalculators 2025 [cited 2026; Available from: https:\/\/statscalculators.com\/calculators\/hypothesis-testing\/ancova-calculator."},{"key":"2294_CR61","volume":"9","author":"KL Jackson","year":"2016","unstructured":"Jackson KL, et al. Better targeting, better efficiency for wide-scale neuronal transduction with the synapsin promoter and AAV-PHP.B. Front Mol Neurosci. 2016;9:116.","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"2294_CR62","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1074\/jbc.M116.744482","volume":"292","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, et al. Neuronal mTORC1 is required for maintaining the nonreactive state of astrocytes. J Biol Chem. 2017;292(1):100\u201311.","journal-title":"J Biol Chem"},{"issue":"4","key":"2294_CR63","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.cmet.2013.08.002","volume":"18","author":"DW Lamming","year":"2013","unstructured":"Lamming DW, Sabatini DM. A central role for mTOR in lipid homeostasis. Cell Metab. 2013;18(4):465\u20139.","journal-title":"Cell Metab"},{"key":"2294_CR64","unstructured":"Patel H and A Bhardwaj, Physiology, Respiratory Quotient, in StatPearls. 2025: Treasure Island (FL)."},{"issue":"21","key":"2294_CR65","doi-asserted-by":"publisher","first-page":"9508","DOI":"10.1128\/MCB.24.21.9508-9516.2004","volume":"24","author":"YG Gangloff","year":"2004","unstructured":"Gangloff YG, et al. Disruption of the mouse mTOR gene leads to early postimplantation lethality and prohibits embryonic stem cell development. Mol Cell Biol. 2004;24(21):9508\u201316.","journal-title":"Mol Cell Biol"},{"issue":"6","key":"2294_CR66","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.devcel.2006.10.007","volume":"11","author":"DA Guertin","year":"2006","unstructured":"Guertin DA, et al. Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1. Dev Cell. 2006;11(6):859\u201371.","journal-title":"Dev Cell"},{"key":"2294_CR67","doi-asserted-by":"publisher","first-page":"102118","DOI":"10.1016\/j.arr.2023.102118","volume":"93","author":"D Yilmaz","year":"2024","unstructured":"Yilmaz D, et al. Mouse models of accelerated aging in musculoskeletal research for assessing frailty, sarcopenia, and osteoporosis - A review. Ageing Res Rev. 2024;93:102118.","journal-title":"Ageing Res Rev"},{"issue":"1","key":"2294_CR68","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1002\/jcsm.12496","volume":"11","author":"M Baraldo","year":"2020","unstructured":"Baraldo M, et al. Skeletal muscle mTORC1 regulates neuromuscular junction stability. J Cachexia Sarcopenia Muscle. 2020;11(1):208\u201325.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"23","key":"2294_CR69","doi-asserted-by":"publisher","first-page":"5055","DOI":"10.1113\/JP283686","volume":"600","author":"M Baraldo","year":"2022","unstructured":"Baraldo M, et al. Inducible deletion of raptor and mTOR from adult skeletal muscle impairs muscle contractility and relaxation. J Physiol. 2022;600(23):5055\u201375.","journal-title":"J Physiol"},{"issue":"10","key":"2294_CR70","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.18632\/aging.101582","volume":"10","author":"J Darcy","year":"2018","unstructured":"Darcy J, et al. Increased environmental temperature normalizes energy metabolism outputs between normal and Ames dwarf mice. Aging (Albany NY). 2018;10(10):2709\u201322.","journal-title":"Aging (Albany NY)"},{"issue":"4","key":"2294_CR71","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1093\/gerona\/gln075","volume":"64","author":"R Westbrook","year":"2009","unstructured":"Westbrook R, et al. Alterations in oxygen consumption, respiratory quotient, and heat production in long-lived GHRKO and Ames dwarf mice, and short-lived bGH transgenic mice. J Gerontol A Biol Sci Med Sci. 2009;64(4):443\u201351.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"2","key":"2294_CR72","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.bbrc.2005.03.206","volume":"331","author":"BA Pederson","year":"2005","unstructured":"Pederson BA, et al. Mice with elevated muscle glycogen stores do not have improved exercise performance. Biochem Biophys Res Commun. 2005;331(2):491\u20136.","journal-title":"Biochem Biophys Res Commun"},{"key":"2294_CR73","unstructured":"Graphical abstract was created in BioRender. Hussong S (2026).\u00a0https:\/\/BioRender.com\/z74661b"}],"container-title":["GeroScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-026-02294-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11357-026-02294-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-026-02294-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T19:03:18Z","timestamp":1778612598000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11357-026-02294-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,12]]},"references-count":73,"alternative-id":["2294"],"URL":"https:\/\/doi.org\/10.1007\/s11357-026-02294-9","relation":{},"ISSN":["2509-2723"],"issn-type":[{"value":"2509-2723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,12]]},"assertion":[{"value":"4 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}]}}